Quarterly Transactions Made in Denali Therapeutics Inc. (DNLI)
This table provides information about the institutional ownership of Denali Therapeutics Inc. (DNLI). The information is specifically focused on institutions that hold shares of Denali Therapeutics Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 4,288,295 | 5,374,242 | 9,662,537 | 2,668,678 | 1,491,457 | 4,160,135 | 5,502,402 | |
| Q4 2021 | 4,078,335 | 1,517,791 | 5,596,126 | 2,200,240 | 1,903,058 | 4,103,298 | 1,492,828 | |
| Q1 2022 | 4,764,209 | 221,998 | 4,986,207 | 3,844,536 | 1,532,509 | 5,377,045 | -390,838 | |
| Q2 2022 | 3,996,913 | 6,992,298 | 10,989,211 | 3,939,967 | 245,635 | 4,185,602 | 6,803,609 | |
| Q3 2022 | 4,184,339 | 2,763,946 | 6,948,285 | 6,812,981 | 0 | 6,812,981 | 135,304 | |
| Q4 2022 | 16,311,876 | 4,883,990 | 21,195,866 | 2,624,260 | 0 | 2,624,260 | 18,571,606 | |
| Q1 2023 | 5,312,718 | 5,316,357 | 10,629,075 | 5,650,612 | 64,400 | 5,715,012 | 4,914,063 | |
| Q2 2023 | 7,078,505 | 1,612,197 | 8,690,702 | 6,218,983 | 831,809 | 7,050,792 | 1,639,910 | |
| Q3 2023 | 5,232,799 | 1,905,292 | 7,138,091 | 2,778,651 | 943,404 | 3,722,055 | 3,416,036 | |
| Q4 2023 | 4,836,133 | 13,520,770 | 18,356,903 | 5,366,666 | 0 | 5,366,666 | 12,990,237 | |
| Q1 2024 | 12,210,579 | 12,821,372 | 25,031,951 | 6,397,367 | 0 | 6,397,367 | 18,634,584 | |
| Q2 2024 | 13,022,161 | 4,002,240 | 17,024,401 | 7,250,932 | 0 | 7,250,932 | 9,773,469 | |
| Q3 2024 | 14,702,664 | 6,568,288 | 21,270,952 | 6,211,161 | 0 | 6,211,161 | 15,059,791 | |